Statistics Flashcards

1
Q

Define Absolute Risk

A

The likelihood of an event occurring in a specific group of people

The number of events in a group, divided by the number of people in that group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the absolute risk control (ARC)?

A

Absolute risk in the control group (i.e. number of events in control arm divided by total numbers in control arm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the absolute risk treatment (ART)?

A

Absolute risk in the treatment group (i.e. number of events in treatment arm divided by total numbers in treatment arm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Absolute risk reduction

A

ARC - ART

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Number needed to treat

A

1 / Absolute risk reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Relative Risk

A

Relative risk is a ratio of the probability of an event occurring in the exposed group versus the probability of the event occurring in the non-exposed group

ART / ARC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Relative Risk Reduction

A

(ARC - ART) / ARC or 1 - RR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sensitivity

A

TP / (TP + FN)
If someone has a disease,
how often will the test be
positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Specificity

A

TN / (TN + FP)
If someone doesn’t have a
disease, how often will the
test be negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Positive Predictive Value

A

TP / (TP + FP)
Probability that if the test result
is positive, the individual does
actually have the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Negative Predictive Value

A

TN / (FN + TN)
Probability that if the test result
is negative, the individual
doesn’t actually have the
disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Prevalence?

A

The proportion of a population found to have a condition. e.g. 1 in 10,000.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Incidence?

A

The probability of occurrence of a given medical condition in a population within a specified period of time. E.g. 1 in 10,000 per year.

It can be thought of as the rate of proliferation in the population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Odds Ratio

A

Odds of the event : non-event
OR = 1 is no difference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the main problems associated with meta-analysis?

A

Publication bias
Language bias
Replication bias
Requires some homogeneity between studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is type 1 (α) error

A

Incorrect rejection of the null hypothesis (that no significant difference exists) - aka finding a difference when none exists

17
Q

What is a type 2 error?

A

Incorrect acceptance of the null hypothesis - aka finding no difference when one exists

18
Q

What are observational studies?

A

The investigatordoes not assign exposures, but there can be comparison groups
With comparison groups =>analytical study
- Cohort study
- Case-control study
- Cross-sectional study

Without comparison groups =>descriptive study
- Case report
- Case series

19
Q

What is the hierarchy of medical evidence?

A

1a) Systematic review of RCTs
1b) Individual well designed RCT
1c) All or none study
2a) Systematic review of Cohort studies
2b) Individual cohort study
3a) Systematic review of case-control studies
3b) Individual case-control study
4) Case-series
5) Expert opinion, bench research, first principles

20
Q

What is the grading of recommendation for scientific literature?

A

A - Consistent level 1 studies
B - Consistent level 2 or 3 studies, or extrapolations from level 1
C - Level 4 studies, or extrapolations from level 2 or 3
D - Level 5 evidence, or troubling/inconsistent studies at any level

21
Q

Describe the process required for drug approval

A

Pre-clinical studies
Phase 0
- First in human
- Micro dosing
- Preliminary data on pharmacokinetics

Phase 1
- Healthy volunteers
- Dose-ranging

Phase 2
- Larger groups
- Efficacy testing

Phase 3 => at least 2 required to market
- RCTs to assess efficacy

Phase 4
- Post-marketing surveillance

22
Q

What was the OPTIMISE (2014) trial investigating?

A

In high-risk patients undergoing gastrointestinal surgery, does a cardiac output-guided haemodynamic therapy algorithm compared to clinician-guided standard therapy reduce death and major morbidity within 30 days?

23
Q

What was the intervention protocol in OPTIMISE?

A

Colloid and dopexamine administration from induction of anaesthesia to 6 hours after end of surgery guided by LiDCO monitor.
250ml bolus colloid over 5 minutes – positive response if rise in stroke volume of at least 10% sustained for 20 minutes.

24
Q

What was the outcome from OPTIMISE?

A

There was a reduction in 30 day composite adverse major outcomes, but not statistically significant (p = 0.07).
No difference in other end points

25
Q

What factors affect the positive predictive value?

A

Sensitivity, specificity and prevalence

26
Q

What is the positive likelihood ratio?

A

Sensitivity / (1 - specificity)
Effect of a positive test on the probability of disease

27
Q

What is the negative likelihood ratio?

A

(1 - sensitivity) / specificity
Effect of a negative test on the probability of disease

28
Q
A